New options in anticoagulation for the prevention of venous thromboembolism and stroke.

摘要

Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism (PE), is a national health problem that affects more than 200,000 Americans each year.VTE causes significant morbidity and mortality, surpassed only by coronary heart disease and stroke.Atrial fibrillation, the most common arrhythmia, is responsible for one-third of embolic stroke in the U.S. VTE and atrial fibrillation more commonly affect the elderly population; therefore, the incidence of both conditions can be expected to increase as the elderly population increases in number.